UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000021555
Receipt No. R000024834
Official scientific title of the study Safety and efficacy of polyphosphate for the treatment of ulcerative colitis(AMU002-CR01)
Date of disclosure of the study information 2016/03/31
Last modified on 2018/09/25 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Safety and efficacy of polyphosphate for the treatment of ulcerative colitis(AMU002-CR01)
Title of the study (Brief title) Safety and efficacy of polyphosphate for the treatment of ulcerative colitis(AMU002-CR01)
Region
Japan

Condition
Condition Ulcerative colitis
Classification by specialty
Gastroenterology Gastrointestinal surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess the safety and efficacy of polyphosphate in the treatment of ulcerative colitis
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Frequency and grade of adverse events due to 4-week administration of polyphosphate for the treatment of ulcerative colitis
Key secondary outcomes Efficacy of 4-week administration of polyphosphate for improvements in clinical and histological inflammation and the expressions of pro-inflammatory cytokines in the treatment of ulcerative colitis

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Oral administration of polyphosphate
Step 1 300mg/day of polyphosphate, after meal in the mornig everyday for 28 days
Step 2 1000mg/day of polyphosphate, after meal in the morning everyday for 28 days
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with refractory ulcerative colitis (Mayo score, 3 to 8; rectal bleeding score, 1 or more; endoscopic subscore, 2 or more)
Key exclusion criteria Patients with drug allergies, renal failure, liver dysfunction, malignancies, pregnancy, history of bowel surgery, infectious colitis, irritable bowel disease, hyperthyroidism or hyperphosphatemia
Patients who are judged to be ineligible by the chief study conductor or doctor in charge
Target sample size 10

Research contact person
Name of lead principal investigator Mikihiro Fujiya
Organization Asahikawa Medical University
Division name Division of Gastroenterology and Hematology/Oncology, Department of Medicine
Address 2-1-1-1, Midorigaoka-higashi, Asahikawa, Hokkaido, Japan
TEL 81-166-68-2462
Email fjym@asahikawa-med.ac.jp

Public contact
Name of contact person Mikihiro Fujiya
Organization Asahikawa Medical University
Division name Division of Gastroenterology and Hematology/Oncology, Department of Medicine
Address 2-1-1-1, Midorigaoka-higashi, Asahikawa, Hokkaido, Japan
TEL 81-166-68-2462
Homepage URL
Email fjym@asahikawa-med.ac.jp

Sponsor
Institute Asahikawa Medical University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 03 Month 31 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 03 Month 14 Day
Anticipated trial start date
2016 Year 04 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 03 Month 22 Day
Last modified on
2018 Year 09 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024834